JP2024540691A5 - - Google Patents

Info

Publication number
JP2024540691A5
JP2024540691A5 JP2024549576A JP2024549576A JP2024540691A5 JP 2024540691 A5 JP2024540691 A5 JP 2024540691A5 JP 2024549576 A JP2024549576 A JP 2024549576A JP 2024549576 A JP2024549576 A JP 2024549576A JP 2024540691 A5 JP2024540691 A5 JP 2024540691A5
Authority
JP
Japan
Prior art keywords
optionally substituted
alkyl
conjugate according
range
aromatic residue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024549576A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024540691A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2022/081345 external-priority patent/WO2023083900A1/en
Publication of JP2024540691A publication Critical patent/JP2024540691A/ja
Publication of JP2024540691A5 publication Critical patent/JP2024540691A5/ja
Pending legal-status Critical Current

Links

JP2024549576A 2021-11-09 2022-11-09 リン(v)および薬物部分を含むコンジュゲート Pending JP2024540691A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP21207195.5 2021-11-09
EP21207195 2021-11-09
PCT/EP2022/081345 WO2023083900A1 (en) 2021-11-09 2022-11-09 Conjugates comprising a phosphorus (v) and a drug moiety

Publications (2)

Publication Number Publication Date
JP2024540691A JP2024540691A (ja) 2024-10-31
JP2024540691A5 true JP2024540691A5 (cg-RX-API-DMAC7.html) 2025-11-17

Family

ID=78592631

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024549576A Pending JP2024540691A (ja) 2021-11-09 2022-11-09 リン(v)および薬物部分を含むコンジュゲート

Country Status (15)

Country Link
US (2) US20230330258A1 (cg-RX-API-DMAC7.html)
EP (1) EP4429708A1 (cg-RX-API-DMAC7.html)
JP (1) JP2024540691A (cg-RX-API-DMAC7.html)
KR (1) KR20240100413A (cg-RX-API-DMAC7.html)
CN (1) CN118302197A (cg-RX-API-DMAC7.html)
AU (1) AU2022385379A1 (cg-RX-API-DMAC7.html)
CA (1) CA3237371A1 (cg-RX-API-DMAC7.html)
CL (1) CL2024001372A1 (cg-RX-API-DMAC7.html)
CO (1) CO2024005877A2 (cg-RX-API-DMAC7.html)
DE (1) DE22817174T1 (cg-RX-API-DMAC7.html)
ES (1) ES2999335T1 (cg-RX-API-DMAC7.html)
IL (1) IL312675A (cg-RX-API-DMAC7.html)
MX (1) MX2024005546A (cg-RX-API-DMAC7.html)
PE (1) PE20242107A1 (cg-RX-API-DMAC7.html)
WO (1) WO2023083900A1 (cg-RX-API-DMAC7.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL321506A (en) * 2022-12-22 2025-08-01 Tubulis Gmbh Conjugates comprising a phosphorus(v) moiety and a drug
WO2025027529A1 (en) 2023-07-31 2025-02-06 Advesya Anti-il-1rap antibody drug conjugates and methods of use thereof
KR20260065883A (ko) 2023-09-01 2026-05-11 투불리스 게엠베하 포스포나미데이트 화합물의 제조 방법
TW202530255A (zh) 2023-12-15 2025-08-01 法商亞維西亞有限公司 抗il-1rap結合結構域及其抗體-藥物偶聯物
WO2025149667A1 (en) 2024-01-12 2025-07-17 Pheon Therapeutics Ltd Antibody drug conjugates and uses thereof
US12521446B2 (en) 2024-02-27 2026-01-13 Bristol-Myers Squibb Company Anti-CEACAM5 antibody drug conjugates
WO2025262641A1 (en) 2024-06-19 2025-12-26 Pheon Therapeutics Ltd Antibody drug conjugates that bind cdcp1 and uses thereof
WO2026096695A1 (en) 2024-10-31 2026-05-07 Bristol-Myers Squibb Company Anti-fucosyl-gm1 antibody drug conjugates
WO2026107136A1 (en) 2024-11-14 2026-05-21 Bristol-Myers Squibb Company Anti-ceacam5 antibody drug conjugates for the treatment of cancer
WO2026105061A1 (en) 2024-11-15 2026-05-21 Pheon Therapeutics Ltd Antibody-drug conjugates that bind cdcp1 and uses thereof
US20260144885A1 (en) 2024-11-22 2026-05-28 Bristol-Myers Squibb Company Anti-lrrc15 antibodies and uses thereof
US20260144884A1 (en) 2024-11-22 2026-05-28 Bristol-Myers Squibb Company Anti-lrrc15 antibody drug conjugates

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US633410A (en) 1898-09-22 1899-09-19 George A Ames Ice-cutter.
EP0401384B1 (en) 1988-12-22 1996-03-13 Kirin-Amgen, Inc. Chemically modified granulocyte colony stimulating factor
US5208020A (en) 1989-10-25 1993-05-04 Immunogen Inc. Cytotoxic agents comprising maytansinoids and their therapeutic use
JP2763020B2 (ja) 1995-04-27 1998-06-11 日本電気株式会社 半導体パッケージ及び半導体装置
US5672662A (en) 1995-07-07 1997-09-30 Shearwater Polymers, Inc. Poly(ethylene glycol) and related polymers monosubstituted with propionic or butanoic acids and functional derivatives thereof for biotechnical applications
EP0859841B1 (en) 1995-08-18 2002-06-19 MorphoSys AG Protein/(poly)peptide libraries
EP1731174A3 (en) 1996-08-02 2007-01-17 Ortho-McNeil Pharmaceutical, Inc. Polypeptides having a covalently bound N-terminal polyethylene glycol via hydrazone or oxime bond
ES2369542T3 (es) 2002-07-31 2011-12-01 Seattle Genetics, Inc. Conjugados de auristatina y su uso para tratar cáncer, una enfermedad autoinmune o una enfermedad infecciosa.
NZ588884A (en) 2008-04-30 2013-05-31 Immunogen Inc Cross-linkers and their uses
PT3057585T (pt) 2013-10-15 2020-10-21 Seagen Inc Fármaco-ligadores peguilados para farmacocinética melhorada de conjugados de fármaco-ligando
WO2018041985A1 (en) 2016-09-01 2018-03-08 Forschungsverbund Berlin E.V. Chemoselective thiol-conjugation with alkene or alkyne-phosphonamidates
US12453779B2 (en) 2018-03-07 2025-10-28 Forschungsverbund Berlin E.V. Chemoselective thiol-conjugation with alkene or alkyne-phosphonothiolates and -phosphonates
TWI920652B (zh) 2018-06-07 2026-04-01 美商思進公司 喜樹鹼結合物

Similar Documents

Publication Publication Date Title
JP7861064B2 (ja) 抗体-薬物コンジュゲート用のグリコシド含有ペプチドリンカー
US20240173427A1 (en) Glypican 3 antibodies and conjugates thereof
ES2999335T1 (en) Conjugates comprising a phosphorus (v) and a drug moiety
JP2023082096A (ja) エリブリンをベースとする抗体-薬物コンジュゲート及び使用方法
JP6165168B2 (ja) 抗糖尿病化合物
US10004812B2 (en) Antibody-drug conjugates and immunotoxins
AU2015215015B2 (en) Antibody-drug conjugates and immunotoxins
JP6585600B2 (ja) C末端軽鎖ポリペプチド伸長を含有する抗体、ならびにその複合体及びその使用方法
JP2023134472A (ja) 抗メソセリン抗体およびその抗体薬物コンジュゲート
TW202010498A (zh) 喜樹鹼肽結合物
JP2022530524A5 (cg-RX-API-DMAC7.html)
JP2023515845A (ja) 抗-cd56抗体-薬物複合体およびその治療での使用
JP2017537893A5 (cg-RX-API-DMAC7.html)
TW202203978A (zh) 電荷可變連接子
BR112021010364A2 (pt) Composições farmacêuticas que compreendem conjugados de anticorpo-fármaco anti-191p4d12 e métodos de uso das mesmas
JP2024545170A5 (cg-RX-API-DMAC7.html)
AU2015340370A9 (en) Materials and methods relating to linkers for use in protein drug conjugates
JP2024532304A (ja) 抗体-薬物コンジュゲートを使用する方法
JP2024529506A (ja) ネクチン-4に特異的な抗体および抗体複合体、並びにそれらの使用方法
CN120957758A (zh) 大环化合物及其制备方法和用途
BR112021005465A2 (pt) agentes de ligação biespecíficos direcionados ao sindecano-1 e receptor do fator de crescimento de fibroblasto
CA3038427C (en) Non-linear self-immolative linkers and conjugates thereof
JP2025513664A5 (cg-RX-API-DMAC7.html)
BR112016018005B1 (pt) Conjugados anticorpo-droga e imunotoxinas